Exscientia plc
DelistedCIK 1865408fmd_0Y6MAHRRWZ5JAKV4D0FSXM72NQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Sep 30, 2024, 16 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | 9 | 10 | 27 | 27 | 20 |
| Cost of revenue | 6 | 14 | 17 | 33 | 27 |
| Gross profit | 3 | (5) | 10 | (6) | (7) |
| Research and development | 7 | 11 | 44 | 129 | 128 |
| Operating income | (8) | (23) | (55) | (145) | (176) |
| Interest expense | 0 | 0 | 0 | 0 | 1 |
| Income before taxes | (8) | (24) | (56) | (141) | (162) |
| Income tax expense | (2) | (2) | (7) | (22) | (16) |
| Net income from continuing operations | (6) | (22) | (49) | (119) | (146) |
| Net income | (6) | (22) | (49) | (119) | (146) |
| Net income to common shareholders | (6) | (22) | (49) | (119) | (146) |